Davis Jennifer L. 4
4 · PROCTER & GAMBLE Co · Filed Apr 30, 2025
Insider Transaction Report
Form 4
Davis Jennifer L.
CEO - Health Care
Transactions
- Sale
Common Stock
2025-04-29$161.38/sh−1,000$161,384→ 51,964.918 total - Award
Restricted Stock Units
2025-02-18+22.16→ 179.886 total→ Common Stock (22.16 underlying)
Holdings
- 14,838.411(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Weighted average price of the shares sold. The price range was $161.38 to $161.40. Full information regarding the number of shares sold at each separate price available upon request.
- [F2]Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.
- [F3]Reflects adjustment to PST through March 31, 2025.
- [F4]Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
- [F5]These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.